|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Interest receivable | |||||
| Non-cash lease expense | |||||
| Loss on write-off of note receivable | |||||
| Change in fair value of contingent acquisition payments | |||||
| Credit (recoveries) losses, net | |||||
| Increase (decrease) from changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Prepaid expenses and other current assets | |||||
| Tax receivable | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Sale of marketable securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from sale of common stock | |||||
| Payments made for taxes of employees who surrendered shares related to unrestricted stock | |||||
| Repurchase of common stock | |||||
| Net cash used in financing activities | |||||
| (Decrase) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosure: | |||||
| Cash paid for income taxes | |||||
Loading...
